Page last updated: 2024-12-08
2-hexyl-4-pentynoic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2-hexyl-4-pentynoic acid: has hepatoprotective activity; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 175664 |
| SCHEMBL ID | 3857718 |
| MeSH ID | M0548973 |
Synonyms (26)
| Synonym |
|---|
| AKOS015837674 |
| 2-prop-2-ynyloctanoic acid |
| 2-propargyloctanoic acid |
| H0964 |
| 2-(2-propynyl)octanoic acid |
| 2-hexyl-4-pentynoic acid |
| 96017-59-3 |
| A845531 |
| 2-(prop-2-yn-1-yl)octanoic acid |
| octanoic acid, 2-(2-propyn-1-yl)- |
| FT-0642317 |
| SCHEMBL3857718 |
| 2-n-hexyl-4-pentynoic acid |
| 2-hexyl-4-pentynoic acid, aldrichcpr |
| mfcd00946863 |
| AS-60204 |
| DTXSID70914685 |
| 2-(prop-2-ynyl)octanoic acid |
| T73101 |
| WDA01759 |
| CS-0068537 |
| hpa; hexyl-4-pentynoic acid |
| HY-118783 |
| PD018756 |
| SY052778 |
| 2-(2-propyn-1-yl)octanoic acid |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 13.18
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.18) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||